What it's for (Indications)
- Flucloxacillin is a narrow-spectrum beta-lactam antibiotic primarily indicated for the treatment of infections caused by penicillinase-producing staphylococci and other Gram-positive bacteria susceptible to its action.
- Its main applications include skin and soft tissue infections, such as cellulitis, impetigo, carbuncles, furunculosis, and infected wounds or burns.
- It is also effectively used in the management of osteomyelitis and septic arthritis, endocarditis, pneumonia, and septicaemia where the causative organism is known or highly suspected to be flucloxacillin-sensitive.
- Furthermore, it plays a role in surgical prophylaxis in procedures where staphylococcal infection is a significant risk.
- The selection of flucloxacillin should be based on susceptibility testing and local epidemiological data to ensure appropriate antimicrobial stewardship and patient safety.
- This antibiotic is crucial for targeting specific resistant bacterial strains that render standard penicillins ineffective, thereby providing a vital therapeutic option in various clinical settings.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | The dosage of flucloxacillin varies significantly depending on the severity and type of infection, the patient's age, weight, and renal function. For adults, typical oral doses range from 250 mg to 500 mg, administered four times daily (every 6 hours). In more severe infections, or for parenteral administration (intravenous or intramuscular), doses may be increased to 1g to 2g every 6 hours. For children, dosage is typically weight-based, often around 12.5 to 25 mg/kg four times daily, with specific adjustments for neonates and infants. In cases of impaired renal function, dosage reduction is often necessary to prevent accumulation and potential toxicity, guided by creatinine clearance levels. For example, in severe renal impairment (creatinine clearance < 10 mL/min), the dosage interval may need to be extended or the dose reduced. Treatment duration is also highly dependent on the infection, ranging from a few days for mild skin infections to several weeks for osteomyelitis or endocarditis, requiring careful clinical judgment and monitoring. |
Safety & Warnings
Common Side Effects
- Flucloxacillin, like other antibiotics, can cause a range of side effects, most of which are mild and transient.
- Common adverse reactions include gastrointestinal disturbances such as nausea, vomiting, diarrhoea, and abdominal discomfort.
- Skin reactions, including rashes (urticarial or maculopapular), pruritus, and fever, are also frequently reported, sometimes indicating a hypersensitivity reaction.
- More serious, albeit less common, adverse effects include anaphylaxis, a severe and potentially life-threatening allergic reaction requiring immediate medical intervention.
- A significant concern is hepatotoxicity, presenting as cholestatic jaundice or hepatitis, which can develop several weeks after treatment cessation and, rarely, can be fatal.
- This risk is higher in older patients, those with pre-existing liver disease, or those on prolonged therapy.
- Other serious side effects include pseudomembranous colitis, caused by *Clostridioides difficile* overgrowth, manifesting as severe and persistent diarrhoea.
- Rarely, haematological abnormalities (e.
- g.
- , neutropenia, thrombocytopenia, haemolytic anaemia) and renal impairment (interstitial nephritis) have been observed.
- Patients should be counselled to report any unusual or severe symptoms promptly to their healthcare provider.
Serious Warnings
- Black Box Warning: Flucloxacillin does not carry an FDA-mandated Black Box Warning. However, clinicians and patients must be fully aware of several serious risks associated with its use, warranting a **Serious Warnings** section. The most critical serious warning pertains to the potential for severe and sometimes fatal hepatotoxicity. This can manifest as cholestatic jaundice or hepatitis, with onset often delayed for several weeks after cessation of treatment. The risk is elevated in patients over 50 years of age, particularly males, and in those with prolonged treatment durations or pre-existing liver disease. Liver function tests should be closely monitored, and treatment should be discontinued if signs of hepatic dysfunction emerge. Another significant concern is the risk of severe hypersensitivity reactions, including anaphylaxis, which can be life-threatening. A comprehensive allergy history is imperative before initiating therapy. Patients with a history of penicillin or cephalosporin allergy are at increased risk. Should any signs of an allergic reaction appear, flucloxacillin must be immediately discontinued, and appropriate emergency treatment instituted. Pseudomembranous colitis, caused by *Clostridioides difficile*, is another serious warning, characterized by severe diarrhea that may occur during or after antibiotic treatment and requires immediate diagnosis and management.
- Careful consideration and monitoring are required when prescribing flucloxacillin due to potential serious adverse reactions.
- Patients should be thoroughly questioned regarding any history of hypersensitivity reactions to penicillins, cephalosporins, or other beta-lactam antibiotics, as cross-reactivity can occur, leading to severe anaphylactic reactions.
- Immediate discontinuation is mandatory at the first sign of an allergic reaction.
- A major warning pertains to the risk of severe hepatotoxicity, including cholestatic jaundice and hepatitis, which can manifest up to several weeks after the cessation of treatment.
- Patients with a history of liver dysfunction or those aged over 50, particularly males, appear to be at increased risk.
- Liver function tests should be monitored, especially in prolonged courses or high-risk individuals.
- Pseudomembranous colitis, caused by *Clostridioides difficile*, is another significant warning, potentially leading to severe, persistent diarrhoea and requiring prompt diagnosis and management.
- Renal impairment necessitates dosage adjustment to prevent drug accumulation and toxicity.
- Prolonged use may lead to superinfection with non-susceptible organisms, including fungi, and may require monitoring for signs of new infections.
- This medication should only be used when a clear bacterial infection is present, adhering to principles of antimicrobial stewardship.
How it Works (Mechanism of Action)
Flucloxacillin exerts its bactericidal effect by interfering with bacterial cell wall synthesis. As a member of the penicillin class, it belongs to the beta-lactam antibiotics, characterized by a beta-lactam ring structure. Its unique resistance to beta-lactamase (penicillinase) enzymes, produced by many staphylococci, is conferred by the addition of a bulky side chain to the penicillin nucleus, specifically the fluorine and chlorine atoms on the isoxazolyl group. This structural modification prevents the enzymatic hydrolysis of the beta-lactam ring, which is essential for the antibiotic's activity. Flucloxacillin selectively and irreversibly binds to penicillin-binding proteins (PBPs) located inside the bacterial cell membrane. PBPs are transpeptidases involved in the final cross-linking steps of peptidoglycan synthesis, a crucial component of the bacterial cell wall. By inhibiting these PBPs, flucloxacillin prevents the formation of a stable, intact bacterial cell wall, leading to increased osmotic pressure, cell lysis, and ultimately, bacterial death. This targeted action makes it highly effective against susceptible Gram-positive bacteria, particularly *Staphylococcus aureus* strains that produce penicillinase.